| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 12 insiders with recent SEC Form 4 filings, including 1 buy and 15 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 374.1K | $3.10M | - | |
| CEO | 305.4K | $2.53M | - | |
| VP | 202.2K | $1.67M | - | |
| VP | 185.6K | $1.54M | - | |
| VP | 162.1K | $1.34M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2015 | El-Hibri Fuad | Chairman | Sell | 29,766 | $34.50 | $1,026,927.00 | -1.6% | |
| Jul 20, 2015 | El-Hibri Fuad | Chairman | Sell | 234 | $34.50 | $8,073.00 | - | |
| Jul 13, 2015 | Richard Ronald | Director | Sell | 4,922 | $34.00 | $167,348.00 | -20.9% | |
| Jun 29, 2015 | Richard Ronald | Director | Sell | 4,923 | $32.76 | $161,277.48 | -17.3% | |
| Jun 22, 2015 | El-Hibri Fuad | Chairman | Sell | 74,564 | $32.60 | $2,431,048.00 | -1.3% | |
| Jun 16, 2015 | Sullivan Louis W62 | Director | Sale+OE | 13,457 | $31.32 | $421,540.52 | -32.1% | |
| Jun 15, 2015 | Havey Adam | EVP, Biodefense Divison | Sale+OE | 36,298 | $31.55 | $1,145,052.60 | -24.2% | |
| Jun 15, 2015 | El-Hibri Fuad | Chairman | Sell | 45,436 | $32.18 | $1,462,328.55 | -0.8% | |
| Jun 1, 2015 | Havey Adam | EVP, Biodefense Divison | Buy | 98 | $27.08 | $2,653.84 | +0.2% | |
| May 26, 2015 | Hauer Jerome M | Director | Sell | 500 | $30.54 | $15,272.15 | -2.9% |